Dynamic Technology Lab Private LTD Novo Cure LTD Transaction History

Dynamic Technology Lab Private LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $265,840 - $350,218	3,910 New	3,910 $297,000
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $537,019 - $754,594	-8,928 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $133,642 - $217,142	1,780 Added 24.9%	8,928 $670,000
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $830,383 - $1.39 Million	7,148 New	7,148 $830,000
Q3 2020 Nov 13, 2020	SELL	$58.05 - $111.31 $1.63 Million - $3.13 Million	-28,158 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $1.61 Million - $2.1 Million	28,158 New	28,158 $1.67 Million
Q1 2020 May 13, 2020	SELL	$57.05 - $95.75 $618,479 - $1.04 Million	-10,841 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$68.3 - $93.8 $740,440 - $1.02 Million	10,841 New	10,841 $914,000
Q4 2017 Feb 09, 2018	SELL	$16.3 - $21.9 $567,696 - $762,733	-34,828 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$18.05 - $21.75 $628,645 - $757,509	34,828	34,828 $691,000

262

76.9M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.75B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.